L. Fardet, I. Petersen, and I. Nazareth, Description of oral glucocorticoid prescriptions in general population]. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, pp.594-603, 2011.

A. Perdoncini-roux, T. Blanchon, T. Hanslik, A. Lasserre, C. Turbelin et al., General practitioners' perception of the impact of corticosteroid-induced adverse events]. Rev Dépidémiologie Santé Publique, pp.93-100, 2009.

L. Fardet, A. Flahault, A. Kettaneh, K. Tiev, T. Généreau et al., Corticosteroid-induced clinical adverse events: frequency, risk factors and patient?s opinion, British Journal of Dermatology, vol.31, issue.3, pp.142-150, 2007.
DOI : 10.1093/rheumatology/keh594

E. Sarnes, L. Crofford, M. Watson, G. Dennis, H. Kan et al., Incidence and US Costs of Corticosteroid-Associated Adverse Events: A Systematic Literature Review, Clinical Therapeutics, vol.33, issue.10, 2011.
DOI : 10.1016/j.clinthera.2011.09.009

C. Arena, A. Morin, T. Blanchon, T. Hanslik, J. Cabane et al., Impact of glucocorticoid-induced adverse events on adherence in patients receiving long-term systemic glucocorticoid therapy, British Journal of Dermatology, vol.66, issue.4, pp.832-839, 2010.
DOI : 10.1111/j.1365-2133.2010.09877.x

E. Morrison, D. Crosbie, and H. Capell, Attitude of rheumatoid arthritis patients to treatment with oral corticosteroids, Rheumatology, vol.42, issue.10, pp.1247-50, 2003.
DOI : 10.1093/rheumatology/keg355

L. Zerah, C. Arena, A. Morin, T. Blanchon, J. Cabane et al., [Patients' beliefs about longterm glucocorticoid therapy and their association to treatment adherence]. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, 2012.

G. Cullen, E. Kelly, and F. Murray, Patients' knowledge of adverse reactions to current medications, British Journal of Clinical Pharmacology, vol.62, issue.2, pp.232-238, 2006.
DOI : 10.1016/S0002-9343(97)00207-6

J. Poisson, M. Six, C. Morin, and L. Fardet, Glucocorticoid therapy: what is the information sought by patients? Traffic analysis of the website cortisone-info.fr]. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, pp.255-262, 2013.

L. Fardet, A. Kassar, J. Cabane, and A. Flahault, Corticosteroid-Induced Adverse Events in Adults, Drug Safety, vol.34, issue.4, pp.861-81, 2007.
DOI : 10.2165/00002018-200730100-00005

L. Fardet, Glucocorticoid-induced adverse events in patients with giant cell arteritis or polymyalgia rheumatica]. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, pp.438-481, 2013.

D. Ziegler, M. Mosier, M. Buenaver, and K. Okuyemi, How much information about adverse effects of medication do patients want from physicians? Arch Intern Med, pp.706-719, 2001.

V. Trewin and G. Veitch, Patient sources of drug information and attitudes to their provision: a corticosteroid model, Pharmacy World and Science, vol.25, issue.5, pp.191-197, 2003.
DOI : 10.1023/A:1025810603241

A. Site-web-de-l-'hcup-elixhauser and P. Owens, Healthcare Cost and Utilization Project Adverse Drug Events in U.S. Hospitals, 2004: Statistical Brief #29 Rockville (MD): Agency for Health Care Policy and Research (US), Consulté le 21 janvier 2015]. Disponible sur internet, 2006.

D. Huscher, K. Thiele, E. Gromnica-ihle, G. Hein, W. Demary et al., Dose-related patterns of glucocorticoid-induced side effects, Annals of the Rheumatic Diseases, vol.68, issue.7, pp.1119-1143, 2009.
DOI : 10.1136/ard.2008.092163

J. Curtis, A. Westfall, J. Allison, J. Bijlsma, A. Freeman et al., Populationbased assessment of adverse events associated with long-term glucocorticoid use. Arthritis Rheum, Jun, vol.1555, issue.3, pp.420-426, 2006.

L. Fardet, I. Petersen, and I. Nazareth, Suicidal Behavior and Severe Neuropsychiatric Disorders Following Glucocorticoid Therapy in Primary Care, American Journal of Psychiatry, vol.169, issue.5, pp.491-498
DOI : 10.1176/appi.ajp.2011.11071009

T. Menckeberg, M. Bouvy, M. Bracke, A. Kaptein, H. Leufkens et al., Beliefs about medicines predict refill adherence to inhaled corticosteroids, Journal of Psychosomatic Research, vol.64, issue.1, pp.47-54, 2008.
DOI : 10.1016/j.jpsychores.2007.07.016

URL : http://dspace.library.uu.nl:8080/handle/1874/32598

J. Howland, M. Baker, and T. Poe, Does patient education cause side effects? A controlled trial, J Fam Pract, vol.31, issue.1, pp.62-66, 1990.

G. Lamb, S. Green, and J. Heron, Can physicians warn patients of potential side effects without fear of causing those side effects? Arch Intern Med, pp.2753-2759, 1994.

R. Horne, R. Parham, R. Driscoll, and A. Robinson, Patients?? attitudes to medicines and adherence to maintenance treatment in inflammatory bowel disease, Inflammatory Bowel Diseases, vol.15, issue.6, pp.837-881, 2009.
DOI : 10.1002/ibd.20846

R. Horne and J. Weinman, Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness, Journal of Psychosomatic Research, vol.47, issue.6, 1999.
DOI : 10.1016/S0022-3999(99)00057-4

D. Morisky, L. Green, and D. Levine, Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care, pp.67-74, 1986.

I. Arnet, C. Metaxas, P. Walter, D. Morisky, and K. Hersberger, The 8-item Morisky Medication Adherence Scale translated in German and validated against objective and subjective polypharmacy adherence measures in cardiovascular patients, Journal of Evaluation in Clinical Practice, vol.8, issue.9, 2015.
DOI : 10.1111/jep.12303

R. Haynes, D. Taylor, D. Sackett, E. Gibson, C. Bernholz et al., Can simple clinical measurements detect patient noncompliance? Hypertension, pp.757-64, 1980.
DOI : 10.1161/01.hyp.2.6.757

URL : http://bcrsrc.jhmi.edu/courses/c34066001/haynes_measurements_noncompliance article_1980.pdf